指南与共识炎症性肠病胃肠动力与功能性疾病

专家意见/方法:常见变异型免疫缺陷病胃肠道表现的临床表现、诊断考虑和治疗选择

An Expert Opinion/Approach: Clinical Presentations, Diagnostic Considerations, and Therapeutic Options for Gastrointestinal Manifestations of Common Variable Immune Deficiency.
指南 / 共识 · Am J Gastroenterol · 2022-01-01

本文综述常见变异型免疫缺陷病(CVID)胃肠道表现的临床表现、诊断考虑和治疗选择。CVID诊断需定量免疫球蛋白检测,IgG至少低于年龄特异性标准差2倍,并伴IgA或IgM降低及疫苗应答受损证据。Ig治疗对感染性并发症有正面影响,但对非感染性表现效果有限。

要点

  • CVID患者多在诊断前有5-9年症状史。
  • 诊断需IgG至少低于年龄特异性标准差2倍,伴低IgA或IgM及疫苗应答受损。
  • Ig治疗对感染性并发症有效,对非感染性表现效果有限。

核心结论

  • 本综述讨论CVID胃肠道表现的临床表现、诊断考虑和治疗选择,以促进个体化管理。

研究设计与样本

  • 综述,检索范围原文未报告。

主要发现

  • CVID是最常见的症状性原发性免疫缺陷,以B细胞分化受损为特征。
  • 多数患者诊断前症状持续5-9年。
  • Ig治疗对感染性并发症有正面影响,但对非感染性表现效果有限,因非感染性并发症与B细胞和T细胞免疫失调相关。
  • CVID胃肠道受累可模仿乳糜泻、恶性贫血或炎症性肠病。

关键数值与推荐

  • 怀疑CVID时应检查定量免疫球蛋白以确认诊断。
  • IgG应至少低于年龄特异性标准差2倍,同时伴低IgA或IgM及疫苗应答受损证据。
  • 类炎症性肠病病变通常用类固醇、5-氨基水杨酸、硫嘌呤类或生物制剂控制炎症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Common variable immunodeficiency (CVID) is the most common symptomatic primary immunodeficiency. It is characterized by impaired B-cell differentiation. Although patients can be diagnosed with CVID anytime during their lifetime, most patients have symptoms for 5-9 years before their diagnosis. The diagnosis of CVID starts with a detailed history focusing on the infectious and noninfectious manifestations of the disease. In patients who are suspected to experience CVID, quantitative immunoglobulins (Ig) should be checked to confirm the diagnosis. IgG should be at least 2 times less than the age-specific SD along with either a low IgA or IgM and with evidence of impaired vaccine response. CVID is usually associated with infectious and/or noninfectious conditions, the latter of which can be inflammatory, autoimmune, lymphoproliferative, or malignant, among other manifestations. Ig therapy has positively affected the disease course of patients with infectious complications but has limited effect on the noninfectious manifestations because the noninfectious complications are related to immune dysregulation involving B cells and T cells rather than primarily due to antibody deficiency. When the gastrointestinal (GI) system is involved, patients with CVID may display signs and symptoms that mimic several GI conditions such as celiac disease, pernicious anemia, or inflammatory bowel diseases. The inflammatory bowel disease-like condition is usually treated with steroids, 5-aminosalicylates, thiopurines, or biologic agents to control the inflammation. In this review, the clinical presentations, diagnostic considerations, and therapeutic options for GI manifestations of CVID will be discussed to facilitate the individualized management of these often-complex patients.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Hashash JG, Squire J, Francis FF, et al. An Expert Opinion/Approach: Clinical Presentations, Diagnostic Considerations, and Therapeutic Options for Gastrointestinal Manifestations of Common Variable Immune Deficiency. Am J Gastroenterol. 2022. PMID: 36148549. doi:10.14309/ajg.0000000000002027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。